The highest court in the land is poised to make a ruling that will undoubtedly change the face of healthcare forever. As the Supreme Court is set to bury or uphold President Obama's presidential campaign healthcare plan, there should be one question that people should be asking no matter what the outcome is. What's next? If the Supreme Court doesn't strike down the individual mandate portion of the plan, the component that would push families to either pay for coverage (generally with help from the tax subsidies) or pay a fine, then the question remains how are we going to...
In the past, med-tech firms have had the luxury of ignoring emerging markets and thereby negating the risk associated with penetrating these markets. Now companies can ill afford to continue this practice since these areas are starting to offer tremendous benefits over existing and established markets. A new report co-sponsored by PriceWaterhouse Coopers (PwC, New York) and published by Axendia (Yardley, Pennsylvania) points out the key concerns and issues that med-tech companies face when investing in these markets. Additional sponsors of the study include, Camstar Systems (Charlotte) and iGATE (Fremont, California).
Fifteen minutes isn't an awful lot of time in some cases, especially when it comes to diabetes patient's meeting with their physicians to discuss possible changes in medication. However, results from a recent study, "Mobile Diabetes Intervention for Glycemic Control: Impact on Physician Prescribing Behavior," show that a patient's visit with their doctor can be greatly enhanced with WellDoc's (Baltimore) Clinical Decision Support.
